HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Ketorolac Tromethamine

HCID 84003
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
74103-07-4
Standard SMILES
NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
InChIKey
BWHLPLXXIDYSNW-UHFFFAOYSA-N
Molecular formula
C19H24N2O6
Average molar mass
376.4 g/mol
Monoisotopic mass
376.16343649

Overview

ROX-888 is ROXRO's lead compound which is currently in Phase 3 trials for the treatment of acute pain, including post-operative pain.

Names & identifiers

Preferred name
Ketorolac Tromethamine
IUPAC
2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
English name
Ketorolac tromethamine
Molecular formula
C19H24N2O6
Molecular weight
376.41

Names & synonyms

Ketorolac tromethamine74103-07-4ToradolKetorolac trometamolAcularAcuvailLixidolDolacAcular LSSPRIXTarasynAcular Preservative Free
Show more names
syntexKetorolac (Toradol)Ketorolac ThromethamineKETOROLAC TROMETHAMINE SALTGodekKetanovKetorolTarazyn
DTXSID0045597NSC-7586374EVE5946BQDTXCID301476271OMIDRIA COMPONENT KETOROLAC TROMETHAMINECHEBI:6130Toronova SUIKAcunivive 15

Database identifiers

CAS
74103-07-4
PubChem CID
84003
DTXSID
DTXSID0045597
ChEMBL
CHEMBL1201124
UNII
4EVE5946BQ
EC Number
620-545-3

Properties

Computed structural properties

Topological polar surface area
146 Ų
Hydrogen bond donors
5
Hydrogen bond acceptors
7
Rotatable bonds
6
Heavy atoms
27
Formal charge
0
Complexity
430

Experimental & physicochemical properties

Solubility>56.5 [ug/mL] (The mean of the results at pH 7.4)
Human Drugs · 3 items

Breast Feeding; Lactation; Milk, Human; Analgesic Agents; Anti-inflammatory Agents, Nonsteroidal

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section155.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
160 · 160-161 C
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: 15 mg/mL stable at least one month at −20 °C., soluble
form
crystalline
color
White to Light yellow
biological source
synthetic (organic)
Water Solubility
2 O: · H2O: soluble 15mg/mL, clear, colorless to faintly yellow (stable at least one month at -20 °C.)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (96.9%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 64 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 3 (96.9%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Ketorolac tromethamine

vLess-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

PPE
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
wgk
3
rtecs
UY7759900
ridadr
UN 2811 6.1/PG 3
hs_code
2933995500
risk_code
25-36/37/38-23/24/25

Chemistry & industry

Pharmacology

Mechanism of Action · 1 item

ROX-888 is a intranasal formulation of the broadly used injectible analgesic, ketorolac. It has ability to provide effective analgesia in acute medical conditions resulting in moderate-severe pain, without the disabling side effects of opioid analgesics

FDA Pharmacological Classification · 2 items

KETOROLAC TROMETHAMINE

Nonsteroidal Anti-inflammatory Drug [EPC]; Cyclooxygenase Inhibitor [EPC]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]

MeSH Pharmacological Classification · 2 items

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.

Applications · 6 items

DescriptionKetorolac tromethamine is a nonsteroidal antiinflammatory agent that exhibits analgesic and antipyretic activity. The compound is effective in the management of moderate to severe postoperative pain. It is, however, the first of this type of agent to be administered parenterally as an analgesic and is specifically indicated for intramuscular injection. Ketorolac represents a useful alternative to the narcotic analgesics due to its lack of abuse potential.

DescriptionKetorolac is a non-steroidal anti-inflammatory drug (NSAID) and a non-selective COX inhibitor (IC50 = 20 nM for both COX-1 and COX-2). It prevents increases in paw swelling, increases paw withdrawal latency in a hot-plate test, and decreases prostaglandin E2 (PGE2) levels in paw tissue in a mouse model of carrageenan-induced inflammation when administered at a dose of 30 mg/kg. Ketorolac is a racemic mixture containing the active (S)-ketorolac and inactive (R)-ketorolac enantiomers. Formulations containing ketorolac have been used to manage postoperative pain and as ophthalmic solutions to treat ocular pain and inflammation.

Related reactions

7 records
New reaction record
HRID 430838 reaction equation
HRID 430838As product
HRID 636077 reaction equation
HRID 636077As product
HRID 636078 reaction equation
HRID 636078As product
HRID 636079 reaction equation
HRID 636079As product
HRID 636080 reaction equation
HRID 636080As product
HRID 1531415 reaction equation
HRID 1531415As product
HRID 1534756 reaction equation
HRID 1534756As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
λmax
322 nm · 322nm(MeOH)(lit.)
Merck
14 · 14,5306
Stability
Hygroscopic
InChI
InChI=1S/C15H13NO3.C4H11NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13;5-4(1-6,2-7)3-8/h1-7,11H,8-9H2,(H,18,19);6-8H,1-3,5H2
InChIKey
BWHLPLXXIDYSNW-UHFFFAOYSA-N
SMILES
C(N)(CO)(CO)CO.C(C1C=CC=CC=1)(C1=CC=C2C(C(=O)O)CCN12)=O
CAS DataBase Reference
74103 · 74103-07-4(CAS DataBase Reference)
FDA UNII
4 EVE5946BQ · 4EVE5946BQ
NCI Drug Dictionary
ketorolac tromethamine
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
301 · H301-H315-H319-H335
Precautionary statements
301 · P301+P310+P330-P302+P352-P305+P351+P338
target organs
Respiratory system
PPE
2 · Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
Hazard Codes
T
Risk Statements
25 · 25-36/37/38-23/24/25
Safety Statements
26 · 26-45-36/37/39
RIDADR
2811 · UN 2811 6.1/PG 3
WGK Germany
3 · 3
RTECS
7759900 · UY7759900
HazardClass
6.1 · 6.1(a)
PackingGroup
II
HS Code
2933995500 · 2933995500
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 OralEye · Acute Tox. 3 OralEye Irrit. 2Skin Irrit. 2STOT SE 3
Limited Quantities
5 L · 5.0 L (1.3 gallons) (liquid) or 5.0 kg (11 lbs) (solid)
Excepted Quantities
Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)
Signal word
Danger
Symbol(GHS)
GHS06
hazard_code
T
safety_code
26-45-36/37/39
hazard_class
6.1(a)
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
II
target organs
Respiratory system
Hazard statements
H301-H315-H319-H335
Limited Quantities
5.0 L (1.3 gallons) (liquid) or 5.0 kg (11 lbs) (solid)
Excepted Quantities
Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)
Hazard Classifications
Acute Tox. 3 OralEye Irrit. 2Skin Irrit. 2STOT SE 3
Precautionary statements
P301+P310+P330-P302+P352-P305+P351+P338

UsesAnalgesic;Cyclooxygenase Inhibitor

UsesKetorolac is used primarily for its analgesic effects for short-term treatment of mild to moderate pain in dogs and rodents. The duration of analgesic effect in dogs is about 8 – 12 hours, but because of the availability of approved, safer NSAIDs for dogs, its use is questionable.

UsesCyclo-oxygenase inhibitor; analgesic; anti-inflammatory.

General DescriptionPharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Ketorolac Tromethamine belongs to the class of non-steroidal anti-inflammatory drugs, and its mode of action involves the inhibition of the bodily synthesis of prostagladins. It exhibits anti-inflammatory, antipyretic and analgesic effects.

Upstream & downstream products

Upstream raw materials

Methylmagnesium chlorideDiethylene Glycol Dibutyl EtherBenzoyl chloridePhosphorus tribromideSodium hydroxide3-EthylanilineTriethylamine4-Chlorobutyryl chloridePhosphorus oxychlorideDiglymePyrrolePhosphorus oxitrichloride
Additional notes · 1 item

DefinitionChEBI: An organoammonium salt resulting from the mixture of equimolar amounts of ketorolac and tromethamine (tris). It has potent non-sedating analgesic and moderate anti-inflammatory effects. It is used in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis.